AQR Arbitrage’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

AQR Arbitrage’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-427,666	Closed	-$32.2M	–	1559
2022 Q2	$32.2M	Buy	+427,666	New	+$19M	0.73%	20

AQR Arbitrage's TPTX Position: Q3 2022 in Review

AQR Arbitrage sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 427,666 shares — an estimated $32.2M sold.

AQR Arbitrage first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $32.2M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

AQR Arbitrage reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
AQR Arbitrage sold 427,666 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $32.2M.
AQR Arbitrage first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
AQR Arbitrage's Turning Point Therapeutics, Inc. Common Stock position peaked at $32.2M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on AQR Arbitrage's 13F filing for Q3 2022, filed 14 Nov 2022.